Kusurinomadoguchi, Inc. (JP:5592)
:5592
Want to see JP:5592 full AI Analyst Report?
5592 Stock Chart & Stats
¥2661.00
-¥9.00(-0.63%)
At close: 4:00 PM EST
¥2661.00
-¥9.00(-0.63%)
Day’s Range― - ―
52-Week Range¥2,000.00 - ¥4,685.00
Previous CloseN/A
Volume47.70K
Average Volume (3M)73.92K
Market Cap
¥31.59B
Enterprise Value¥28.67B
Total Cash (Recent Filing)¥1.89B
Total Debt (Recent Filing)¥56.01M
Price to Earnings (P/E)15.0
Beta0.76
Next Earnings
May 20, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend Yield1.03%
Share Statistics
EPS (TTM)44.36
Shares Outstanding11,455,582
10 Day Avg. Volume72,500
30 Day Avg. Volume73,916
Financial Highlights & Ratios
PEG Ratio0.10
Price to Book (P/B)2.65
Price to Sales (P/S)2.00
P/FCF Ratio-4.17
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)169.1
Revenue Forecast (FY)¥13.70B
Bulls Say, Bears Say
Bulls Say
Revenue GrowthSustained top-line expansion across 2022–2025 reflects structural demand for digital pharmacy services and increasing platform adoption. Durable revenue growth supports scale economics, greater bargaining power with partners, and provides a runway to invest in product, distribution, and retention initiatives over the medium term.
Margin ExpansionMaterial improvement in gross and net margins indicates structural profitability gains from higher take-rates, operational leverage, or better mix. If sustained, higher margins improve free cash generation potential per revenue dollar and provide capacity for R&D, marketing, or strategic partnerships without proportional increases in fixed costs.
Conservative Current Leverage & High ROEVery low reported leverage and strong ROE give the company financial flexibility to fund growth, M&A, or absorb shocks without heavy interest burdens. A conservatively levered capital structure supports resilient strategic execution and reduces refinancing risk over the 2–6 month horizon.
Bears Say
Deteriorating Cash GenerationSharp negative operating and free cash flows despite reported profit indicate weak cash conversion or one-off cash drains. Persistent cash shortfalls constrain reinvestment, dividend capacity, and may force external financing, increasing long-term funding cost and execution risk if not remedied.
Balance Sheet VolatilityLarge year-to-year swings in leverage and a material asset decline reduce predictability of capital structure and may reflect asset disposals, impairments, or volatile working capital. This volatility complicates long-term planning and raises the likelihood of periodic financing or restructuring needs.
Profitability Spike May Be UnsustainableA sudden jump in margins and net income can reflect non-recurring items, accounting timing, or transient efficiencies. If earnings improvements are not repeatable, future profit expectations and related investment plans could be disappointed, undermining long-term cash flow reliability and strategic decisions.
Kusurinomadoguchi, Inc. News
5592 FAQ
What was Kusurinomadoguchi, Inc.’s price range in the past 12 months?
Kusurinomadoguchi, Inc. lowest stock price was ¥2000.00 and its highest was ¥4685.00 in the past 12 months.
What is Kusurinomadoguchi, Inc.’s market cap?
Kusurinomadoguchi, Inc.’s market cap is ¥31.59B.
When is Kusurinomadoguchi, Inc.’s upcoming earnings report date?
Kusurinomadoguchi, Inc.’s upcoming earnings report date is May 20, 2026 which is in 30 days.
How were Kusurinomadoguchi, Inc.’s earnings last quarter?
Kusurinomadoguchi, Inc. released its earnings results on Feb 13, 2026. The company reported ¥44.36 earnings per share for the quarter, beating the consensus estimate of N/A by ¥44.36.
Is Kusurinomadoguchi, Inc. overvalued?
According to Wall Street analysts Kusurinomadoguchi, Inc.’s price is currently Overvalued.
Does Kusurinomadoguchi, Inc. pay dividends?
Kusurinomadoguchi, Inc. pays a Notavailable dividend of ¥30 which represents an annual dividend yield of 1.03%. See more information on Kusurinomadoguchi, Inc. dividends here
What is Kusurinomadoguchi, Inc.’s EPS estimate?
Kusurinomadoguchi, Inc.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Kusurinomadoguchi, Inc. have?
Kusurinomadoguchi, Inc. has 11,455,582 shares outstanding.
What happened to Kusurinomadoguchi, Inc.’s price movement after its last earnings report?
Kusurinomadoguchi, Inc. reported an EPS of ¥44.36 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went down -2.572%.
Which hedge fund is a major shareholder of Kusurinomadoguchi, Inc.?
Currently, no hedge funds are holding shares in JP:5592
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Kusurinomadoguchi, Inc.
Kusurinomadoguchi, Inc. provides solutions for pharmacies and medical care in Japan. The company offers EPARK drug counter, a pharmacy/drugstore search and reservation site; matching site to buy and sell dead stock medicines at dispensing pharmacies; site for medicine counter telephone medical treatment; Health Tech Navi, an electronic medication history system; Care Daisy system to link recording systems and ICT devices; solution for purchasing pharmaceuticals; and system that allows for centralized management of outpatient reception, outpatient reservations, and online medical treatment. It also provides Pharmacy Support, a customer management system for repeat patients in the pharmacy industry; system specialized for dispensing pharmacies; matching service that connects nursing care facilities and pharmacies; solution from the purchase of pharmaceuticals to the purchase of immovable inventory; Online consultation by hospital support; online medication guidance; support solution to pharmacies; EPARK medicine notebook, a medication notebook that allows to make dispensing reservations and manage family medicines; and a system that allows patients to select the pharmacy they want to visit. The company was founded in 2004 and is headquartered in Tokyo, Japan.